Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference

NEXT STORY
Trevena Announces TRV027 Selected by NIH-Funded ACTIV Initiative For COVID-19 Trial
PREV STORY
Madrigal Pharmaceuticals Reports 2021 First Quarter Financial Results and Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tarsus Pharmaceuticals, Inc. to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

author_avatar
NASDAQ Market News

Basilea announces the start of the offer period of its partial repurchase offer for its outstanding convertible bonds due 2022

author_avatar
NASDAQ Market News

Altimmune Announces Third Quarter 2019 Financial Results and Provides a Business Update

author_avatar
NASDAQ Market News